ImmunityBio, Inc.
IBRX· Nasdaq
ImmunityBio, Inc.
- Last sale
- Oct 2, 2026 · +10.76%
- Market cap
- $10.91B
- 1.06B shares
- Filings
- 550
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $113,288,000 | reported | |
| FY 2024 | 2024-12-31 | $14,745,000 | reported | |
| FY 2023 | 2023-12-31 | $622,000 | reported | |
| FY 2022 | 2022-12-31 | $240,000 | reported | |
| FY 2021 | 2021-12-31 | $934,000 | reported | |
| FY 2020 | 2020-12-31 | $605,000 revised | reported | |
| FY 2019 | 2019-12-31 | $2,202,000 revised | reported | |
| FY 2018 | 2018-12-31 | $47,000 | reported | |
| FY 2017 | 2017-12-31 | $45,000 | reported | |
| FY 2016 | 2016-12-31 | $44,000 | reported | |
| FY 2015 | 2015-12-31 | $236,000 | reported | |
| FY 2014 | 2014-12-31 | $641,000 | reported |
ImmunityBio, Inc. · CIK 1326110 · Engraved from SEC EDGAR
